Results 61 to 70 of about 9,370 (262)

Rapid bedside inactivation of Ebola virus for safe nucleic acid tests [PDF]

open access: yes, 2016
Rapid bedside inactivation of Ebola virus would be a solution for the safety of medical and technical staff, risk containment, sample transport and high-throughput or rapid diagnostic testing during an outbreak.
Bragstad, Karoline   +9 more
core   +1 more source

Clinical Management of Filovirus-Infected Patients

open access: yesViruses, 2012
Filovirus infection presents many unique challenges to patient management. Currently no approved treatments are available, and the recommendations for supportive care are not evidence based.
Danielle V. Clark   +2 more
doaj   +1 more source

Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing? [PDF]

open access: yes, 2000
The recent outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo has put the filovirus threat back on the international health agenda.
Boelaert, M   +7 more
core   +3 more sources

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages

open access: yesViruses, 2019
Macrophages are one of the first and also a major site of filovirus replication and, in addition, are a source of multiple cytokines, presumed to play a critical role in the pathogenesis of the viral infection. Some of these cytokines are known to induce
Tzanko S. Stantchev   +5 more
doaj   +1 more source

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species. [PDF]

open access: yesPLoS ONE, 2012
Filoviruses cause sporadic but highly lethal outbreaks of hemorrhagic fever in Africa in the human population. Currently, no drug or vaccine is available for treatment or prevention.
Roland Zahn   +14 more
doaj   +1 more source

Cellular Factors Implicated in Filovirus Entry [PDF]

open access: yesAdvances in Virology, 2013
Although filoviral infections are still occurring in different parts of the world, there are no effective preventive or treatment strategies currently available against them. Not only do filoviruses cause a deadly infection, but they also have the potential of being used as biological weapons.
Suchita Bhattacharyya, Thomas J. Hope
openaire   +4 more sources

Filovirus Replication and Transcription [PDF]

open access: yesFuture Virology, 2007
The highly pathogenic filoviruses, Marburg and Ebola virus, belong to the nonsegmented negative-sense RNA viruses of the order Mononegavirales. The mode of replication and transcription is similar for these viruses. On one hand, the negative-sense RNA genome serves as a template for replication, to generate progeny genomes, and, on the other hand, for ...
openaire   +3 more sources

Filovirus Mimics Deliver Effectively [PDF]

open access: yesBiophysical Journal, 2016
Filoviruses such as Ebola are microns long but biophysical advantages for such encapsulating/enveloped viruses have remained obscure. Flexible ‘filomicelles’ have been made from amphiphilic block copolymers and demonstrate effective delivery of two very different hydrophobic compounds.
Afsaneh Lavasanifar   +4 more
openaire   +2 more sources

Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses. [PDF]

open access: yes, 2017
Until recently, immune responses in filovirus survivors remained poorly understood. Early studies revealed IgM and IgG responses to infection with various filoviruses, but recent outbreaks have greatly expanded our understanding of filovirus immune ...
Agrati   +54 more
core   +4 more sources

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector

open access: yesVaccines, 2020
In the infectious diseases field, protective immunity against individual virus species or strains does not always confer cross-reactive immunity to closely related viruses, leaving individuals susceptible to disease after exposure to related virus ...
Sarah Sebastian   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy